Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies

42:34
 
Share
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on May 29, 2025 19:02 (24h ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 484397509 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics:

  • EZH2 Inhibitors for Follicular Lymphoma (FL) (0:00)
  • Bruton Tyrosine Kinase Inhibitors for FL (5:43)
  • Anti-CD19 Antibodies for FL (9:40)
  • Other Novel Agents Under Clinical Development for FL (18:50)
  • Case: A woman in her early 80s with multiple comorbidities and relapsed FL (23:06)
  • Case: A man in his early 40s with high-risk progressive FL that did not achieve deep remission with prior therapy (27:07)
  • Case: A woman in her early 70s with rheumatoid arthritis and relapsed FL (33:46)

CME information and select publications

  continue reading

1579 episodes

Artwork
iconShare
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on May 29, 2025 19:02 (24h ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 484397509 series 1464173
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics:

  • EZH2 Inhibitors for Follicular Lymphoma (FL) (0:00)
  • Bruton Tyrosine Kinase Inhibitors for FL (5:43)
  • Anti-CD19 Antibodies for FL (9:40)
  • Other Novel Agents Under Clinical Development for FL (18:50)
  • Case: A woman in her early 80s with multiple comorbidities and relapsed FL (23:06)
  • Case: A man in his early 40s with high-risk progressive FL that did not achieve deep remission with prior therapy (27:07)
  • Case: A woman in her early 70s with rheumatoid arthritis and relapsed FL (33:46)

CME information and select publications

  continue reading

1579 episodes

Alla avsnitt

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play